Fundraising FoxVenture-Backed Startups
146,408 companies with verified investor relationships.
Agility Forex provides currency and capital movement services using technology for global money transfers. The company combines financial market expertise with modern platforms to facilitate international fund movements.
2 investors
0 investors
0 investors
0 investors
Agility Robotics develops and deploys humanoid robots for warehouse automation and logistics operations. The company manufactures commercial robots that move packages and totes in distribution centers.
17 investors
Agilix provides virtual medical nutrition therapy, connecting patients with registered dietitians for personalized care plans delivered by phone. It supports people managing complex conditions such as cancer, survivorship, pregnancy, menopause, and PCOS, and works with patients, caregivers, providers, and health plans.
0 investors
Agillic is a SaaS company serving B2B enterprise customers for customer experience and digital transformation. The page does not provide sufficient detail about its core product offering or industry focus.
2 investors
Agiloft offers a Contract Lifecycle Management (CLM) and contracts AI platform that centralizes, automates, and governs the contract process from request and negotiation through execution, obligation tracking, and renewal. It serves legal, procurement, finance, sales, and IT teams at enterprises, converting agreements into searchable, queryable data for risk analysis and business intelligence.
4 investors
0 investors
AgileOne (now Acquia CDP) offers a Customer Data Platform that unifies customer data from sources such as websites, mobile, email, POS, and CRM into single customer profiles for marketing teams. It applies machine learning models for segmentation, personalization, and predictive targeting, and includes consent management tools for GDPR and CCPA compliance.
1 investor
agilon health partners with community-based primary-care physician groups, providing capital, data, payor relationships, and operational support so they can take on total-care risk for Medicare patients under a value-based model. Operating in the United States, it offers a Total Care Model and unified platform aimed at improving care for older adults while keeping physician practices independent.
1 investor
0 investors
0 investors
Agilyx develops advanced recycling technology and invests in solutions across the plastics value chain, from feedstock management to chemical recycling, to convert plastic waste into a reusable resource. The company focuses on shifting from a linear economy to a circular model and supporting the low-carbon transition.
2 investors
0 investors
Agio Ratings provides on-chain risk monitoring and modeling for the digital assets market, helping financial institutions track counterparty risks and evaluate probability of default. The platform serves market makers, funds, regulators, banks, and insurers.
2 investors
Agios is a biopharmaceutical company developing therapies for rare diseases, with a primary focus on hemolytic anemias including pyruvate kinase deficiency, thalassemia, and sickle cell disease. The company's approach is grounded in cellular metabolism research and involves close collaboration with patients and clinical partners.
4 investors
Agistics provides routing and scheduling software for feed-delivery fleets, using geo-fenced delivery points, avoidance zones, and real-time driver tracking to reduce delivery errors and improve on-time performance. It serves agricultural and feed logistics operations managing truck fleets.
1 investor
Agita Labs develops hardware security and computer architecture technology focused on secure computation and side-channel resistance techniques. The company applies research in trusted computing and confidential data processing.
1 investor
Agitated Solutions, Inc. (ASI) develops a saline microbubble contrast agent and delivery approach for cardiac bubble studies used to detect right-to-left shunts such as PFOs, aiming to remove manual saline agitation and let a single sonographer perform the study. Its products serve cardiac sonographers and echocardiography clinics, with a lead agent (ASI-02) in a US clinical trial and commercial availability in Canada and the EU.
1 investor
Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment. The firm has invested in 12 early-stage companies since 2004, six of which it founded, and has been involved in developing over 100 oncology products.
1 investor
Aglide extends identity provider access control to applications lacking SAML support, enabling centralized management of user provisioning, deprovisioning, and audit logs across applications.
2 investors
Aglocell develops AI-based algorithms and containerized software solutions for fine-tuning 5G/4G mobile networks, detecting and resolving interference and balancing traffic across cells and bands. Its products help telecom network operators increase capacity, improve cell edge speeds, and reduce infrastructure expansion costs.
0 investors
0 investors